New hope for patients with Werner syndrome
Peer-Reviewed Publication
Updates every hour. Last Updated: 14-Nov-2025 06:12 ET (14-Nov-2025 11:12 GMT/UTC)
Werner syndrome (WS) is a rare genetic disorder that causes premature aging and serious complications. In the first clinical trial of its kind, researchers from Japan with the company Niagen Bioscience, investigated the effects of nicotinamide riboside (NR), a vitamin B3 derivative, in patients with WS. NR supplementation significantly improved cardiovascular health, reduced skin ulcer area, and slowed kidney function decline—offering promising therapeutic potential for a disease that currently lacks effective treatment.
Scientists at the CNIC have developed an innovative method for analyzing the mechanical function of proteins through controlled cleavage.
Stroke survivors with depression or anxiety who attend talking therapy sessions are more likely to recover from their psychological symptoms, finds a new study by UCL researchers.